Alicia Irurzun-Lafitte

Alicia Irurzun-Lafitte joined UCB Ventures in 2019 as Partner. Alicia joined from M Ventures, the corporate venture arm of Merck KGaA where she was instrumental in the closing of multiple investments in Oncology, Immunology and Women’s Health in the US and Europe. She was also closely involved with the built-up of spin-offs. Prior to ventures, Alicia held roles in global business development at Merck Serono in Geneva and EMD Serono in Boston. During her time in business development, she closed several transactions and was involved in strategic corporate development initiatives. Alicia holds a MSc from Leiden University in Biopharmaceutical Sciences and a MBA from Babson College.